Biophytis (BPTSY) Competitors $1.45 0.00 (0.00%) As of 07/3/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock BPTSY vs. SHPH, AKAN, SLRX, ENTO, TNFA, ONCT, BPTH, ADXS, PTEIQ, and ASLNShould you be buying Biophytis stock or one of its competitors? The main competitors of Biophytis include Shuttle Pharmaceuticals (SHPH), Akanda (AKAN), Salarius Pharmaceuticals (SLRX), Entero Therapeutics (ENTO), TNF Pharmaceuticals (TNFA), Oncternal Therapeutics (ONCT), Bio-Path (BPTH), Ayala Pharmaceuticals (ADXS), PolarityTE (PTEIQ), and ASLAN Pharmaceuticals (ASLN). These companies are all part of the "pharmaceutical products" industry. Biophytis vs. Its Competitors Shuttle Pharmaceuticals Akanda Salarius Pharmaceuticals Entero Therapeutics TNF Pharmaceuticals Oncternal Therapeutics Bio-Path Ayala Pharmaceuticals PolarityTE ASLAN Pharmaceuticals Biophytis (NASDAQ:BPTSY) and Shuttle Pharmaceuticals (NASDAQ:SHPH) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, profitability, media sentiment, earnings, risk, dividends, valuation and analyst recommendations. Which has more volatility & risk, BPTSY or SHPH? Biophytis has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Shuttle Pharmaceuticals has a beta of -1.09, suggesting that its share price is 209% less volatile than the S&P 500. Is BPTSY or SHPH more profitable? Biophytis' return on equity of 0.00% beat Shuttle Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets BiophytisN/A N/A N/A Shuttle Pharmaceuticals N/A -1,203.10%-370.42% Which has preferable earnings and valuation, BPTSY or SHPH? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBiophytisN/AN/A-$18.43MN/AN/AShuttle PharmaceuticalsN/AN/A-$9.15M-$4.15-1.02 Do insiders & institutionals believe in BPTSY or SHPH? 0.1% of Biophytis shares are held by institutional investors. Comparatively, 4.6% of Shuttle Pharmaceuticals shares are held by institutional investors. 3.7% of Biophytis shares are held by insiders. Comparatively, 12.6% of Shuttle Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media prefer BPTSY or SHPH? In the previous week, Shuttle Pharmaceuticals had 1 more articles in the media than Biophytis. MarketBeat recorded 1 mentions for Shuttle Pharmaceuticals and 0 mentions for Biophytis. Biophytis' average media sentiment score of 0.00 equaled Shuttle Pharmaceuticals'average media sentiment score. Company Overall Sentiment Biophytis Neutral Shuttle Pharmaceuticals Neutral SummaryShuttle Pharmaceuticals beats Biophytis on 4 of the 7 factors compared between the two stocks. Get Biophytis News Delivered to You Automatically Sign up to receive the latest news and ratings for BPTSY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BPTSY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BPTSY vs. The Competition Export to ExcelMetricBiophytisPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$509K$783.24M$5.47B$8.92BDividend YieldN/A4.84%5.24%4.04%P/E RatioN/A1.3027.0520.14Price / SalesN/A230.51380.7693.83Price / CashN/A23.4426.2128.59Price / Book-0.096.138.005.58Net Income-$18.43M-$27.85M$3.16B$248.40M7 Day Performance5.07%2.28%3.84%6.13%1 Month PerformanceN/A8.43%3.04%7.78%1 Year Performance-78.65%8.64%34.26%20.95% Biophytis Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BPTSYBiophytisN/A$1.45flatN/A-78.6%$509KN/A0.0030SHPHShuttle Pharmaceuticals0.413 of 5 stars$4.34+15.1%N/AN/A$1.91MN/A-1.055High Trading VolumeAKANAkanda0.5562 of 5 stars$1.33-5.0%N/A-70.8%$1.90M$840K0.00110SLRXSalarius Pharmaceuticals0.7151 of 5 stars$0.88-2.1%N/A-63.6%$1.87MN/A-0.1820Gap DownENTOEntero TherapeuticsN/A$0.39-2.4%N/A-62.9%$1.86MN/A0.009Positive NewsTNFATNF PharmaceuticalsN/A$0.12+0.6%N/AN/A$1.75MN/A-0.026Gap DownHigh Trading VolumeONCTOncternal Therapeutics1.7186 of 5 stars$0.53flat$10.00+1,799.0%N/A$1.56M$790K-0.0530BPTHBio-Path0.7436 of 5 stars$0.18+2.9%$20.00+11,328.6%-90.6%$1.45MN/A0.0010ADXSAyala PharmaceuticalsN/A$0.03+22.9%N/A-38.1%$1.42M$3.24M0.0020Gap UpPTEIQPolarityTEN/AN/AN/AN/A$1.24M$810K-0.0560Gap UpASLNASLAN PharmaceuticalsN/A$0.60flatN/AN/A$1.23M$12M-0.0330 Related Companies and Tools Related Companies Shuttle Pharmaceuticals Alternatives Akanda Alternatives Salarius Pharmaceuticals Alternatives Entero Therapeutics Alternatives TNF Pharmaceuticals Alternatives Oncternal Therapeutics Alternatives Bio-Path Alternatives Ayala Pharmaceuticals Alternatives PolarityTE Alternatives ASLAN Pharmaceuticals Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BPTSY) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biophytis S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biophytis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BPTSY Stock Alerts